Abstract: The present invention belongs to the pharmaceutical field, and discloses an anti-ovarian cancer pharmaceutical composition and an action target thereof. The anti-tumor pharmaceutical composition includes a Curcuma zedoaria extract and an Astragalus membranaceus extract, which synergistically enhance the efficacy by combining calycosin and bisdemethoxycurcumin to reduce the pharmaceutical dosage, minimize side effects, and save costs. An MCM2 gene, as an action target of the anti-ovarian cancer pharmaceutical composition, has been discovered. This gene has a significant impact on the proliferation, migration, and invasion abilities of ovarian cancer, providing guidance for the development and screening of a drug for preventing or treating ovarian cancer.

Abstract: A trained machine learning model distinguishes between human-driven accounts and machine-driven accounts by performing anomaly detection based on sign-in data and optionally also based on directory data. This machine versus human distinction supports security improvements that apply security controls and other risk management tools and techniques which are specifically tailored to the kind of account being secured. Formulation heuristics can improve account classification accuracy by supplementing a machine learning model anomaly detection result, e.g., based on directory information, kind of IP address, kind of authentication, or various sign-in source characteristics. Machine-driven accounts masquerading as human-driven may be identified as machine-driven. Reviewed classifications may serve as feedback to improve the model's accuracy. A precursor machine learning model may generate training data for training a production account classification machine learning model.

Abstract: The present invention provides a magnet mount for securely holding a firearm. The magnet mount includes a side mounting plate, one or more magnets are affixed to the side mounting plate, and a firearm holder. The firearm includes (a) a firearm seat, (b) a connector extending upwardly from the firearm seat and connecting to the side mounting plate, and (c) a trigger shield extending upwardly from the firearm seat. The trigger shield is configured for blocking at least 50% of a trigger accessing area of the firearm to prevent accidental discharge. Also provided is a method of securely holding a firearm using the magnet mount.

Abstract: A foldable table includes a support assembly, a tabletop assembly, a rotating assembly and a buffer member. The tabletop assembly is rotatably connected to the support assembly through the rotating assembly and is rotatable between a use position and a storage position. One end of the buffer member is connected to the support assembly, and the other end of the buffer member is connected to the tabletop assembly. When the tabletop assembly rotates from the use position to the storage position, the buffer member generates a resistance opposite to a rotation direction of the tabletop assembly, and a magnitude of the resistance is less than a force driving the rotation of the tabletop assembly. Through the arrangement of the above structure, when folding the foldable table of the present invention, it can not only ensure the integrity of its own structure, but also prevent accidental injury to the user.

Abstract: Methods, systems, apparatuses, and computer-readable storage mediums described herein are configured to detect anomalous post-authentication behavior/state change(s) with respect to a workload identity. For example, audit logs that specify actions performed with respect to the workload identity of a platform-based identity service, a causing state change(s), while another identity is authenticated with the platform-based identity service, are analyzed. The audit log(s) are analyzed via a model for anomaly prediction based on actions. The model generates an anomaly score indicating a probability whether a particular sequence of the actions is indicative of anomalous behavior/state change(s). A determination is made that an anomalous behavior has occurred based on the anomaly score, and when anomalous behavior has occurred, a mitigation action may be performed that mitigates the anomalous behavior.

Abstract: The invention provides a diagnostic kit for metastasis and invasion of breast cancer and a use of an shRNA molecule for silencing expression of human LINC01614. The shRNAs obtained by the invention can interfere with the expression of LINC01614, thereby reducing the migration and invasion ability of tumor cells, inhibiting the expression of EMT proteins, and inhibiting tumor formation and lung metastasis in an animal model in vivo. The invention provides a new solution for targeted therapy of breast cancer. Therefore, the kit for diagnosing metastasis and invasion of breast cancer and the medication for treating metastasis and invasion of breast cancer are developed. The invention provides a new way and strategy for diagnosing and treating metastasis and invasion of breast cancer.

Abstract: Methods, systems, apparatuses, and computer-readable storage mediums described herein are configured to detect anomalous post-authentication behavior/state change(s) with respect to a workload identity. For example, audit logs that specify actions performed with respect to the workload identity of a platform-based identity service, a causing state change(s), while another identity is authenticated with the platform-based identity service, are analyzed. The audit log(s) are analyzed via a model for anomaly prediction based on actions. The model generates an anomaly score indicating a probability whether a particular sequence of the actions is indicative of anomalous behavior/state change(s). A determination is made that an anomalous behavior has occurred based on the anomaly score, and when anomalous behavior has occurred, a mitigation action may be performed that mitigates the anomalous behavior.

Abstract: The present disclosure relates to a portable safety terminal based method for processing rail transit resources, and a system for the method. The method includes: in a degradation mode, performing interaction between a portable safety terminal and a wayside controller; providing a driver with safety display of an environment where a train is located, and obtaining a location of the train and information of a relationship between a front train and a rear train; and providing the driver with a means to apply for line resources, such that the driver can, according to the train environment, autonomously apply for the line resources, and release the resources for use by subsequent trains after driving the train to pass through a zone. Compared to the prior art, the present disclosure has the advantages of improving the safety of train driving and field maintenance operation, etc.

Abstract: The present invention relates to a safety check method and device for coupling of multiple train units in rail transit, and medium, the method including: determining train formation information to obtain the length, weight and traction braking characteristics of the whole train, so as to automatically protect the running of the train on a route and realize automatic driving. Compared with the prior art, the present invention can detect the coupling states of more than 2 marshalled trains.

Abstract: This application relates to a battery module, a battery pack, an apparatus, and a failure handling method. The battery module includes: a plurality of battery units configured to be serially-connected, where the plurality of battery units include a failed battery unit and at least one non-failed battery unit after the battery module fails; and a conductive part, electrically connected to the at least one non-failed battery unit, and configured to make a current bypass an electrode assembly of the failed battery unit so that the battery module resumes working. This application simplifies a maintenance process of the battery module, reduces maintenance cost, and improves working efficiency of the battery module.

Abstract: Methods, systems, apparatuses, and computer-readable storage mediums described herein are configured to detect anomalous post-authentication behavior with respect to a user identity. For example, one or more audit logs that specify a plurality of actions performed with respect to the user identity of a platform-based identity service, while the user identity is authenticated with the platform-based identity service, are analyzed. The audit log(s) are analyzed via an anomaly prediction model that generates an anomaly score indicating a probability whether a particular sequence of actions of the plurality of actions is indicative of anomalous behavior. A determination is made that an anomalous behavior has occurred based on the anomaly score. In response to determining that anomalous behavior has occurred, a mitigation action may be performed that mitigates the anomalous behavior.

Abstract: A flow-coating apparatus is configured to flow-coat a member to be flow-coated with an insulation layer, where the member to be flow-coated includes a first surface and an outer peripheral surface surrounding a periphery of the first surface, the first surface being perpendicular to a vertical direction. The flow-coating apparatus includes a first flow-coating mechanism and a second flow-coating mechanism, where a flow-coating opening of the first flow-coating mechanism faces the first surface and is configured to flow-coat the first surface with the insulation layer; and a flow-coating opening of the second flow-coating mechanism faces the outer peripheral surface and is configured to flow-coat the outer peripheral surface with the insulation layer.

Abstract: Embodiments relate to an insulation assembly for use in a transformer, a transformer assembly for use in a transformer, and a dry type transformer. The insulation assembly includes a plurality of tubular insulation barriers adapted to be arranged around a transformer inner coil to electrically isolate the inner coil from a transformer outer coil, each pair of adjacent tubular insulation barriers being separated by a gap; and an air blocking element arranged in at least one gap between the plurality of tubular insulation barriers to at least partially block an air flow from passing through the at least one gap. According to various embodiments, the air blocking element blocks the cool air from passing through the at least one gap. Thus, more cool air may pass through gas channels near to the inner/outer coils and take away more heat generated by the transformer, thereby improving the cooling efficiency of the transformer.

Abstract: This application relates to a battery module and a battery pack. The battery module includes: a plurality of battery cells, configured to be connected in series, where after the battery module fails, the plurality of battery cells include a failed battery cell and at least one non-failed battery cell adjacent to the failed battery cell; and a first connecting piece, configured to connect the failed battery cell to the at least one non-failed battery cell, where the first connecting piece includes a first connecting portion and a conductive portion connected to the first connecting portion, the first connecting portion is configured to be electrically connected to an enclosure of the failed battery cell, and the conductive portion is configured to be electrically connected to the at least one non-failed battery cell, so as to restore the battery module to work.

Abstract: Provided are a pharmaceutical composition of (S)-ketorolac and a preparation method therefor, which belong to the technical field of pharmaceutical preparations. The pharmaceutical composition includes (S)-ketorolac or a pharmaceutically acceptable salt thereof, a stabilizer, a pH-adjusting agent, and an excipient, and the dosage form of the pharmaceutical composition is preferably lyophilized powder injection. The lyophilized powder injection prepared herein has optical purity of an active ingredient greater than or equal to 95% after being stored under long-term stability test conditions for 6 months and optical purity of an active ingredient greater than or equal to 90% after being stored under accelerated stability test conditions for 6 months. The lyophilized powder injection has important use in the preparation of non-steroidal anti-inflammatory drugs with analgesic, anti-inflammatory, antipyretic effects.

Abstract: A shell includes an insulating layer provided at an outer surface of the shell and including a repair part formed of a curable material and having a shape of a mushroom. The repair part includes an upper part having a shape of a cover of the mushroom and a lower part having a shape of a stem of the mushroom. The lower part is embedded in the insulating layer, the upper part protrudes from the insulating layer, and a lower surface of the upper part covers at least a portion of an upper surface of the insulating layer. In a cross section of the repair part perpendicular to a surface of the insulating layer, a longest dimension of the upper part is greater than or equal to a sum of a width of the lower part and a creepage distance of a battery.

Abstract: The invention provides a diagnostic kit for metastasis and invasion of breast cancer and a use of an shRNA molecule for silencing expression of human LINC01614. The shRNAs obtained by the invention can interfere with the expression of LINC01614, thereby reducing the migration and invasion ability of tumor cells, inhibiting the expression of EMT proteins, and inhibiting tumor formation and lung metastasis in an animal model in vivo. The invention provides a new solution for targeted therapy of breast cancer. Therefore, the kit for diagnosing metastasis and invasion of breast cancer and the medication for treating metastasis and invasion of breast cancer are developed. The invention provides a new way and strategy for diagnosing and treating metastasis and invasion of breast cancer.

Abstract: This application provides a battery module and an assembling method thereof. The battery module includes batteries and busbar components. The batteries are arranged consecutively along a longitudinal direction of the battery module. Each battery includes a first electrode terminal and a second electrode terminal. The busbar components are connected to the batteries. The batteries include a first battery and a second battery. The first electrode terminal of the first battery and the first electrode terminal of the second battery are arranged along the longitudinal direction. The busbar components include a first busbar component, and the first busbar component includes a first part, a second part, and a third part.

Abstract: This application provides a battery and an electric device. The battery provided in this application is provided with a blocking member between two adjacent rows of battery cells along the length direction of the battery cell. In the process of assembling the battery cells in the box, the adhesive at the bottom of the battery cell, when spreading under compressing from the gap created by the housing chamfers to the end cover, will be blocked by the blocking member, thus preventing the adhesive from overflowing to the end cover, improving the safety performance of the battery.

Abstract: The invention provides a medication and a diagnostic kit for inhibiting metastasis and invasion of breast cancer, an shRNA molecule for silencing expression of human LINC01614 and applications thereof. The shRNAs obtained by the invention can interfere with the expression of LINC01614, thereby reducing the migration and invasion ability of tumor cells, inhibiting the expression of EMT proteins, and inhibiting tumor formation and lung metastasis in an animal model in vivo. The invention provides a new solution for targeted therapy of breast cancer. Therefore, the kit for diagnosing metastasis and invasion of breast cancer and the medication for treating metastasis and invasion of breast cancer are developed. The invention provides a new way and strategy for diagnosing and treating metastasis and invasion of breast cancer.